Hectorol

ApprovedSmall molecule

Sanofi

Hectorol is one of 61 small molecule programs targeting Secondary Hyperparathyroidism. It is currently in Approved.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Secondary HyperparathyroidismActive, not recruiting

Chronic Kidney DiseaseActive, not recruiting

Secondary HyperparathyroidismApproved

Active, not recruiting

Chronic Kidney DiseaseApproved

Active, not recruiting

Competition

Competitive Landscape

540 competitors in Chronic Kidney Disease

#DrugCompanyPhaseTrials

Hectorol

Sanofi

Approved

1 2

Aranesp

Amgen

Preclinical

40 3

Lorelco

Sanofi

Preclinical

1 4

Activase

Flomax

Epoetin Beta

5 7

Sodium Valproate

AstraZeneca

Preclinical

4 8

Genotropin

EMD Serono

Preclinical

1 9

Tradjenta

Boehringer Ingelheim

Preclinical

1 10

SGLT2 Inhibitor

Eli Lilly

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Hemodialysis1 trial

A Phase 4 Pharmacokinetic Study of Hectorol Injection and Zemplar Injection in CKD Subjects on Hemodialysis

Completed· Sanofi logo

Sanofi·Phase 4·NCT00454350·12 enrolled

Secondary Hyperparathyroidism1 trial

Study of Safety and Efficacy of Doxercalciferol in Patients With Chronic Kidney Disease, Stage 3 or 4, and Secondary Hyperparathyroidism

Completed· Sanofi logo

Sanofi·Phase 4·NCT00123461·70 enrolled

Dialysis1 trial

A Phase 4, Conversion Study of Hectorol® Injection to Hectorol® Capsules in Stage 5 CKD Patients on Dialysis

Completed· Sanofi logo

Sanofi·Phase 4·NCT00418600·36 enrolled

Chronic Kidney Disease1 trial

A Study of Zemplar® Injection and Hectorol® Injection on Intestinal Absorption of Calcium in Chronic Kidney Disease

Completed·AAbbott·Phase 4·NCT00257920·41 enrolled

Unspecified1 trial

A Phase 4 Study to Determine Dosing of Hectorol® Capsules When Converting From Zemplar® Injection

Completed· Sanofi logo

Sanofi·Phase 4·NCT00463021·36 enrolled

Sources

References

[1]
ClinicalTrials.gov — 5 trial records for Hectorol. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Hectorol compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Hectorol. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Sanofi company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: Sanofi

Hectorol

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Hemodialysis1 trial

Secondary Hyperparathyroidism1 trial

Dialysis1 trial

Chronic Kidney Disease1 trial

Unspecified1 trial

References

Drug Info

Quick Facts

Related News